Evaluating the Cost-Effectiveness of Real-Time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in the Treatment of Patients with Insulin-Treated Type 2 Diabetes in Australia

Hamza Alshannaq; David Simmons; Richard F. Pollock; Moin Uddin Ahmed; Greg J. Norman

doi:10.1007/s12325-025-03430-1

December 5, 2025Advances in TherapyOpen Access

Evaluating the Cost-Effectiveness of Real-Time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in the Treatment of Patients with Insulin-Treated Type 2 Diabetes in Australia

View Full Paper

Ask AI

Bookmark

Share

Key Points

RT-CGM demonstrated significant cost-effectiveness by improving patient outcomes and reducing costs, particularly in subgroups with insulin-treated diabetes.
Findings indicate that real-time continuous glucose monitoring may enhance glycemic management, leading to overall better health for patients.
Assessment involved evaluating outcomes related to blood glucose management in different demographic populations, focusing on Indigenous Australians and younger individuals.
Potential implications include advocating for broader reimbursement policies based on the cost-effectiveness of glucose monitoring technologies.

Implication

Analysis reveals improved patient outcomes with real-time glucose monitoring in insulin-treated T2D, suggesting cost savings.

Abstract

RT-CGM was dominant in both insulin-treated subgroups, improving patient outcomes while reducing healthcare costs. These findings highlight the potential value of RT-CGM for broad reimbursement in Australia and the importance of addressing inequities in glycemic management, particularly among Indigenous Australians and younger individuals with T2D.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Alshannaq et al. (2025) studied this question.

synapsesocial.com/papers/694022442d562116f28fbbe1 https://doi.org/10.1007/s12325-025-03430-1

View Full Paper

Ask AI

Bookmark

Share

Evaluating the Cost-Effectiveness of Real-Time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in the Treatment of Patients with Insulin-Treated Type 2 Diabetes in Australia

Key Points

Implication

Abstract

Discussion

Cite This Study

Evaluating the Cost-Effectiveness of Real-Time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in the Treatment of Patients with Insulin-Treated Type 2 Diabetes in Australia

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading